← 產業報告目錄

Latin America Pharmaceutical Products CMO Market, By Service Type (Contract Manufacturing Services (CMO) {Active Pharmaceutical Ingredient (API) Manufacturing, (Small Molecule APIs, Biologic APIs), Finished Dosage Form (FDF) Manufacturing (Solid Dosage Forms, Injectable Dosage Forms, Semi-solid Dosage Forms, Liquid Dosage Forms), Packaging Services (Primary Packaging, Secondary Packaging), Fill-Finish Services} and Contract Research Services (CRO), (Drug Discovery Services (Target Identification, and Lead Optimization), Preclinical Research (In Vitro Studies, and In Vivo Studies), Clinical Research (Phase I, Phase II, Phase III, Phase IV), Regulatory Affairs Services, Pharmacovigilance Services, Medical Writing Services)), By Product Type (Small Molecule Drugs, Biologics (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Cell & Gene Therapies), and Biosimilars), By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurology, Metabolic Disorders, Respiratory Diseases, Immunology, Rare Diseases, Others), By Geography (Latin America)

出版商 Coherent Market Insights出版日期 2026-07-15頁數 257報告編號 CMR-54c37095d1

授權報價

Single User Price$4,500 USD
Site License Price$7,000 USD
Enterprisewide Price (Global Site License)$10,000 USD
洽詢購買 申請 Sample

報告摘要

Pharmaceutical products CMO provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Contract manufacturing organizations offer services from development of biologics to commercial scale production. Market Dynamics The Latin America pharmaceutical products CMO market is expected to witness significant growth during the forecast period, owing to the increasing expansion of international pharmaceutical companies in Latin America. For instance, in April 2020, the U.S. pharmaceutical company and French corporation Gennisium Pharma entered into the exclusive agreement under which m8 Pharmaceuticals has the exclusive rights to register and commercialize a more suitable formulation of an already existing orphan drug for apnea in Mexico and Brazil. Moreover, additional pipeline products for the treatment of conditions prevalent in premature newborn patients are also included in this partnership. Low healthcare expenditure is expected to hinder growth of Latin America pharmaceutical products CMO market. For instance, according to the survey by Brazil’s Federal Council of Medicine in 2018, per capita public spending on health care in Brazil did not increase above the country’s official inflation, which rose by 80% from 2008 to 2017. Key features of the study • This report provides in-depth analysis of the Latin America pharmaceutical products CMO market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the Latin America pharmaceutical products CMO market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans • Key companies covered as a part of this study include BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmacéutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The Latin America pharmaceutical products CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America pharmaceutical products CMO market Market Segmentation • By Service Type (Revenue, USD Bn, 2021-2033) o Contract Manufacturing Services (CMO)  Active Pharmaceutical Ingredient (API) Manufacturing o Small Molecule APIs o Biologic APIs  Finished Dosage Form (FDF) Manufacturing o Solid Dosage Forms o Injectable Dosage Forms o Semi-solid Dosage Forms o Liquid Dosage Forms  Packaging Services o Primary Packaging o Secondary Packaging  Fill-Finish Services o Contract Research Services (CRO)  Drug Discovery Services o Target Identification o Lead Optimization  Preclinical Research o In Vitro Studies o In Vivo Studies  Clinical Research o Phase I o Phase II o Phase III o Phase IV  Regulatory Affairs Services  Pharmacovigilance Services  Medical Writing Services • By Product Type (Revenue, USD Bn, 2021-2033) o Small Molecule Drugs o Biologics  Monoclonal Antibodies  Recombinant Proteins  Vaccines  Cell & Gene Therapies o Biosimilars • By Therapeutic Area o Oncology o Infectious Diseases o Cardiovascular Diseases o Neurology o Metabolic Disorders o Respiratory Diseases o Immunology o Rare Diseases o Others • By End User o Pharmaceutical Companies o Biotechnology Companies o Generic Drug Manufacturers o Academic & Research Institutes o Government Organizations • By Region (Revenue, USD Bn, 2021-2033) o Latin America  Brazil  Mexico  Argentina  Rest of Latin America • Key Players o BASF SE o Bayer AG o Boehringer Ingelheim GmbH o Hoffmann-La Roche Ltd. o Merck & Co., Inc. o Novartis AG o Pfizer, Inc. o Pisa Farmaceutica o Fresenius SE & Co. KGaA o Takeda Pharmaceutical Company Limited o Ferring Pharmaceuticals, Inc. o Landsteiner Scientific
目錄 Table of Contents
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Service Type  Market Snapshot, By Product Type  Market Snapshot, By Therapeutic Area  Market Snapshot, By End User  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Key Developments o Product Approval o Collaboration/Merge/Acquisition o Regulatory Landscape o PEST Analysis o Porter’s Five Forces Analysis o Epidemiology o Robust Pipeline Analysis 4. Latin America Pharmaceutical Products CMO Market, By Service Type, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Contract Manufacturing Services (CMO)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Active Pharmaceutical Ingredient (API) Manufacturing  Small Molecule APIs  Biologic APIs o Finished Dosage Form (FDF) Manufacturing  Solid Dosage Forms  Injectable Dosage Forms  Semi-solid Dosage Forms  Liquid Dosage Forms o Packaging Services  Primary Packaging  Secondary Packaging o Fill-Finish Services o Contract Research Services (CRO)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Drug Discovery Services  Target Identification  Lead Optimization o Preclinical Research  In Vitro Studies  In Vivo Studies o Clinical Research  Phase I  Phase II  Phase III  Phase IV o Regulatory Affairs Services o Pharmacovigilance Services o Medical Writing Services 5. Latin America Pharmaceutical Products CMO Market, By Product Type, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Small Molecule Drugs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Biologics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Monoclonal Antibodies o Recombinant Proteins o Vaccines o Cell & Gene Therapies o Biosimilars  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) 6. Latin America Pharmaceutical Products CMO Market, By Therapeutic Area, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Oncology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Infectious Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Cardiovascular Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Neurology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Metabolic Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Respiratory Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Immunology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Rare Diseases  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) 7. Latin America Pharmaceutical Products CMO Market, By End User, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022– 2033  Segment Trends o Pharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Biotechnology Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Generic Drug Manufacturers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Academic & Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) o Government Organizations  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Billion) 8. Latin America Pharmaceutical Products CMO Market, By Country, 2021 – 2033, (USD Billion) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2022–2033  Regional Trends o Brazil  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion) o Mexico  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion) o Argentina  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion) o Rest Of Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Billion)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion) 9. Competitive Landscape o Heat Map Analysis o Market Share Analysis o Company Profile  BASF SE o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Bayer AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Boehringer Ingelheim GmbH o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Hoffmann-La Roche Ltd. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Merck & Co., Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Novartis AG o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Pfizer Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Pisa Farmaceutica o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Fresenius SE & Co. KGaA o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Takeda Pharmaceutical Company Limited o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Ferring Pharmaceuticals, Inc. o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies  Landsteiner Scientific o Company Highlights o Product Portfolio o Financial Performance o Recent Highlights o Market Strategies o Analyst Views 10. Section o References o Research Methodology o About Us
圖表清單 List of Tables & Figures
NA NA

提及公司

o BASF SEo Bayer AGo Boehringer Ingelheim GmbHo Hoffmann-La Roche Ltd.o Merck & Co.Inc.o Novartis AGo PfizerInc.o Pisa Farmaceuticao Fresenius SE & Co. KGaAo Takeda Pharmaceutical Company Limitedo Ferring PharmaceuticalsInc.o Landsteiner Scientific

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們